Overcoming Obesity 2022 - Fall Obesity Summit Pediatric Track (Recorded)
-
Add to Cart
- Non-member - $112
- Member - $92
The Fall Obesity Summit will expand your skills used to treat patients with obesity. Session content will explore obesity evaluation and treatment in each of the 4 pillar – pharmacotherapy, nutrition, physical activity, and behavioral modification.
The Pediatric, Adolescent and Young Adult Track is designed to provide clinicians with updated information regarding utilizing advanced tools of weight management, such as anti-obesity medications and metabolic-bariatric surgery, for children, adolescents and young adults with obesity. Clinicians will walk away with a better understanding of how to treat obesity in special pediatric populations, including those with genetic or syndromic obesity, intellectual disabilities, and behavioral issues such as autism spectrum disorder. Clinicians will also learn how to address the unique obesity-related medical and behavioral issues of adolescents transitioning into young adulthood and gender diverse youth.
Advanced Search This List
-
Includes Credits
Janey Pratt, MD, FACS, FASMBS, Allen Browne, MD, FACS, FAAP, Melissa Santos, PhD, Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM participate in a roundtable discussion covers metabolic bariatric surgery in children and adolescents based on the 2018 ASMBS pediatric metabolic and bariatric surgery guidelines.
This roundtable discussion covers metabolic bariatric surgery in children and adolescents based on the 2018 ASMBS pediatric metabolic and bariatric surgery guidelines.
Learning Objectives:
Discuss the criteria, benefits, and risks for MBS in children and adolescents
Discuss changes in the criteria for MBS between the previous guidelines in 2012 and the 2018 guidelines
Review MBS in the context of a child or adolescent with high risk social issues
Review decision making for children and adolescents who are being considered for MBS
-
Includes Credits
Evan Nadler, MD, MBA, and Brooke Sweeney, MD, FAAP, DABOM will overview of assessment and treatment options for children with special needs or medical complexity who also suffer from obesity.
This session will be an overview of assessment and treatment options for children with special needs or medical complexity who also suffer from obesity.
Learning Objectives:
Discuss the assessment of children with special needs and obesity
Review advanced behavioral tools for children with obesity and special healthcare needs
Discover how to use anti-obesity pharmacotherapy in a special needs population and children with medical complexity
Review surgical guidelines and outcomes in children with obesity, and in children with special needs and medical complexity
-
Includes Credits
Evan Nadler, MD, MBA, and Brooke Sweeney, MD, FAAP, DABOM discuss key takeaways from the Advanced Weight Management Tools in Special Populations lecture.
Learning Objectives:
Discuss key takeaways from the Advanced Weight Management Tools in Special Populations lecture
Ask specific questions about managing obesity within the pediatric population in a Q&A panel with faculty experts
-
Includes Credits
Dominique Williams, MD, MPH, Dipl ABOM discusses the complex relationship between weight and body habitus, gender identity and expression that could influence engagement in weight management and attrition within structured programs.
There is very little data to help guide clinicians, despite probable similarities in clinical care and lived experiences that affect gender diverse youth with obesity. There is a complex relationship between weight and body habitus, gender identity and expression that could influence engagement in weight management and attrition within structured programs. Based on the high prevalence of victimization and marginalization, treatment goals should consider the negative impact of these social-related complications. Moreover, gender-affirming hormone therapies may worsen obesity, change body composition, or increase cardiovascular risk. Careful attention to barriers to care as well as medical and behavioral comorbidities can inform care to better support clinicians, patients and gender diverse youth with obesity.
Learning Objectives:
Discuss gender identity, gender expression and gender diversity
Describe how the intersection of obesity and gender identity affects the health of children and adolescents
Explain how some gender-affirming treatments can worsen obesity, increase the risk or exacerbate weight-related complications
Use appropriate language when talking with gender diverse youth with obesity
-
Includes Credits
Eileen Chaves, PhD, Cindi Condos MSN, FNP, and Jennifer Paisley MD, FAAP, Dipl. ABOM will inform clinicians and provide insight and specific recommendations on how to approach healthcare transitions in AYA with obesity.
Most adolescents are not adequately prepared to transition their care from pediatric-oriented to adult-oriented health care. This is especially concerning given the chronic nature of obesity, access to anti-obesity medication, and utilization of metabolic-bariatric surgery in Adolescent Young Adults (AYA). Moreover, healthcare transitions occur at a time when AYA are also trying to navigate other developmental and emotional milestones. Using the combined experiences of a pediatric psychologist, Med-Peds obesity medicine specialist, and Pediatric Obesity Coordinator of a Community Health Clinic, this session will inform clinicians and provide insight and specific recommendations on how to approach healthcare transitions in AYA with obesity.
Learning Objectives:
Review the importance of healthcare transitions in the management of Adolescent Young Adult (AYA) with chronic diseases, including overweight and obesity
Identify developmental challenges and recognize the role of mental health in emotional readiness for AYA transitions
Describe a stepwise obesity treatment plan that considers disease severity, cultural factors, and other social drivers of health unique to Adolescent Young Adults
-
Includes Credits
Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM will review the current state of pharmacology in the treatment of children and adolescents with obesity.
This session will review the current state of pharmacology in the treatment of children and adolescents with obesity.
Learning Objectives:
Review currently approved anti-obesity medications and medication on the horizon for children and adolescents with obesity
Discuss decision making in using anti-obesity medications in children and adolescents with obesity
-
Includes Credits
Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM and Eileen Chaves, PhD will discuss key takeaways from the Pediatric lectures on Transitional Care and Anti-Obesity Medications.
Learning Objectives:
Discuss key takeaways from the Pediatric lectures on Transitional Care and Anti-Obesity Medications
Ask specific questions about managing obesity within the pediatric population in a Q&A panel with faculty experts
-
Includes Credits
Janey Pratt, MD, FACS, FASMBS, Allen Browne, MD, FACS, FAAP, Melissa Santos, PhD, Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM participate in a roundtable discussion covers metabolic bariatric surgery in children and adolescents based on the 2018 ASMBS pediatric metabolic and bariatric surgery guidelines.
This roundtable discussion covers metabolic bariatric surgery in children and adolescents based on the 2018 ASMBS pediatric metabolic and bariatric surgery guidelines.
Learning Objectives:
Discuss the criteria, benefits, and risks for MBS in children and adolescents
Discuss changes in the criteria for MBS between the previous guidelines in 2012 and the 2018 guidelines
Review MBS in the context of a child or adolescent with high risk social issues
Review decision making for children and adolescents who are being considered for MBS
-
Includes Credits
Evan Nadler, MD, MBA, and Brooke Sweeney, MD, FAAP, DABOM will overview of assessment and treatment options for children with special needs or medical complexity who also suffer from obesity.
This session will be an overview of assessment and treatment options for children with special needs or medical complexity who also suffer from obesity.
Learning Objectives:
Discuss the assessment of children with special needs and obesity
Review advanced behavioral tools for children with obesity and special healthcare needs
Discover how to use anti-obesity pharmacotherapy in a special needs population and children with medical complexity
Review surgical guidelines and outcomes in children with obesity, and in children with special needs and medical complexity
-
Includes Credits
Evan Nadler, MD, MBA, and Brooke Sweeney, MD, FAAP, DABOM discuss key takeaways from the Advanced Weight Management Tools in Special Populations lecture.
Learning Objectives:
Discuss key takeaways from the Advanced Weight Management Tools in Special Populations lecture
Ask specific questions about managing obesity within the pediatric population in a Q&A panel with faculty experts
-
Includes Credits
Dominique Williams, MD, MPH, Dipl ABOM discusses the complex relationship between weight and body habitus, gender identity and expression that could influence engagement in weight management and attrition within structured programs.
There is very little data to help guide clinicians, despite probable similarities in clinical care and lived experiences that affect gender diverse youth with obesity. There is a complex relationship between weight and body habitus, gender identity and expression that could influence engagement in weight management and attrition within structured programs. Based on the high prevalence of victimization and marginalization, treatment goals should consider the negative impact of these social-related complications. Moreover, gender-affirming hormone therapies may worsen obesity, change body composition, or increase cardiovascular risk. Careful attention to barriers to care as well as medical and behavioral comorbidities can inform care to better support clinicians, patients and gender diverse youth with obesity.
Learning Objectives:
Discuss gender identity, gender expression and gender diversity
Describe how the intersection of obesity and gender identity affects the health of children and adolescents
Explain how some gender-affirming treatments can worsen obesity, increase the risk or exacerbate weight-related complications
Use appropriate language when talking with gender diverse youth with obesity
-
Includes Credits
Eileen Chaves, PhD, Cindi Condos MSN, FNP, and Jennifer Paisley MD, FAAP, Dipl. ABOM will inform clinicians and provide insight and specific recommendations on how to approach healthcare transitions in AYA with obesity.
Most adolescents are not adequately prepared to transition their care from pediatric-oriented to adult-oriented health care. This is especially concerning given the chronic nature of obesity, access to anti-obesity medication, and utilization of metabolic-bariatric surgery in Adolescent Young Adults (AYA). Moreover, healthcare transitions occur at a time when AYA are also trying to navigate other developmental and emotional milestones. Using the combined experiences of a pediatric psychologist, Med-Peds obesity medicine specialist, and Pediatric Obesity Coordinator of a Community Health Clinic, this session will inform clinicians and provide insight and specific recommendations on how to approach healthcare transitions in AYA with obesity.
Learning Objectives:
Review the importance of healthcare transitions in the management of Adolescent Young Adult (AYA) with chronic diseases, including overweight and obesity
Identify developmental challenges and recognize the role of mental health in emotional readiness for AYA transitions
Describe a stepwise obesity treatment plan that considers disease severity, cultural factors, and other social drivers of health unique to Adolescent Young Adults
-
Includes Credits
Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM will review the current state of pharmacology in the treatment of children and adolescents with obesity.
This session will review the current state of pharmacology in the treatment of children and adolescents with obesity.
Learning Objectives:
Review currently approved anti-obesity medications and medication on the horizon for children and adolescents with obesity
Discuss decision making in using anti-obesity medications in children and adolescents with obesity
-
Includes Credits
Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM and Eileen Chaves, PhD will discuss key takeaways from the Pediatric lectures on Transitional Care and Anti-Obesity Medications.
Learning Objectives:
Discuss key takeaways from the Pediatric lectures on Transitional Care and Anti-Obesity Medications
Ask specific questions about managing obesity within the pediatric population in a Q&A panel with faculty experts
